MYRIAD GENETICS INC (MYGN)

US62855J1043 - Common Stock

13.5  -0.24 (-1.75%)

After market: 13.5 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
690.6M
8.14%
678.4M
-1.77%
753.2M
11.03%
857.3M
13.82%
896.65M
4.59%
977.87M
9.06%
1.077B
10.14%
1.14B
5.85%
EBITDA
YoY % growth
-63.9M
-6.50%
-71M
-11.11%
-75M
-5.63%
38.138M
150.85%
42.929M
12.56%
81.383M
89.58%
119.6M
46.96%
166.26M
39.01%
EBIT
YoY % growth
-126.7M
4.02%
-123.7M
2.37%
-136.9M
-10.67%
20.934M
115.29%
26.583M
26.98%
63.71M
139.66%
86.258M
35.39%
112.76M
30.72%
Operating Margin
-18.35%-18.23%-18.18%2.44%2.96%6.52%8.01%9.89%
EPS
YoY % growth
0.02
102.93%
-0.30
-1,600.00%
-0.28
6.67%
0.13
147.81%
0.10
-22.95%
0.37
254.92%
0.74
103.38%
0.98
31.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.03
-31.66%
0.00
75.21%
0.02
-60.65%
0.04
-38.07%
0.06
115.26%
0.05
2,294.65%
0.08
331.99%
0.08
128.74%
0.11
84.90%
Revenue
Q2Q % growth
217.81M
10.79%
217.23M
7.43%
225.72M
6.72%
224.4M
5.20%
231.72M
6.39%
235.58M
8.45%
245.82M
8.90%
247.49M
10.29%
254.02M
9.62%
EBITDA
Q2Q % growth
8.103M
-79.33%
6.886M
151.39%
11.695M
98.22%
11.341M
-60.35%
14.084M
73.81%
14.586M
111.82%
19.38M
65.71%
18.87M
66.39%
24.48M
73.81%
EBIT
Q2Q % growth
5.646M
124.87%
6.237M
121.43%
10.167M
140.83%
10.36M
158.20%
13.105M
132.11%
39.372M
531.27%
44.88M
341.43%
44.268M
327.30%
49.98M
281.38%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.06
300.00%
0.020.04205.26%
Q2 2024
Q2Q % growth
0.05
162.50%
-0.010.06500.81%
Q1 2024
Q2Q % growth
-0.01
95.24%
-0.110.1090.66%
Q4 2023
Q2Q % growth
0.04
133.33%
0.010.03208.06%
Q3 2023
Q2Q % growth
-0.03
84.21%
-0.080.0563.74%
Q2 2023
Q2Q % growth
-0.08
-300.00%
-0.090.017.73%
Q1 2023
Q2Q % growth
-0.21
-600.00%
-0.20-0.01-6.49%
Q4 2022
Q2Q % growth
-0.12
-500.00%
-0.170.0527.97%
Q3 2022
Q2Q % growth
-0.19
-850.00%
-0.06-0.13-210.46%
Q2 2022
Q2Q % growth
0.04
-66.67%
0.010.03292.16%
Q1 2022
Q2Q % growth
-0.03
50.00%
-0.070.0456.19%
Q4 2021
Q2Q % growth
-0.02
83.33%
-0.020.0015.95%
Q3 2021
Q2Q % growth
-0.02
93.41%
-0.020.001.96%
Q2 2021
Q2Q % growth
0.12
125.27%
-0.090.21235.38%
Q1 2021
Q2Q % growth
-0.06
-884.31%
-0.140.0857.60%
Q4 2020
Q2Q % growth
-0.12 -0.130.014.61%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
213.3M
11.15%
214.94M-1.64M-0.76%
Q2 2024
Q2Q % growth
211.5M
15.26%
209.05M2.45M1.17%
Q1 2024
Q2Q % growth
202.2M
11.59%
197.38M4.82M2.44%
Q4 2023
Q2Q % growth
196.6M
10.57%
198.68M-2.08M-1.05%
Q3 2023
Q2Q % growth
191.9M
22.70%
182.82M9.08M4.97%
Q2 2023
Q2Q % growth
183.5M
2.34%
190.87M-7.37M-3.86%
Q1 2023
Q2Q % growth
181.2M
9.88%
174.98M6.22M3.55%
Q4 2022
Q2Q % growth
177.8M
10.57%
172.85M4.95M2.86%
Q3 2022
Q2Q % growth
156.4M
-6.52%
173.5M-17.1M-9.86%
Q2 2022
Q2Q % growth
179.3M
-5.33%
174.42M4.88M2.80%
Q1 2022
Q2Q % growth
164.9M
-4.74%
159.76M5.14M3.22%
Q4 2021
Q2Q % growth
160.8M
4.01%
166.67M-5.87M-3.52%
Q3 2021
Q2Q % growth
167.3M
15.22%
168.34M-1.04M-0.62%
Q2 2021
Q2Q % growth
189.4M
103.22%
168.42M20.98M12.46%
Q1 2021
Q2Q % growth
173.1M
5.55%
159.33M13.77M8.64%
Q4 2020
Q2Q % growth
154.6M
-20.76%
153.4M1.2M0.78%
Q3 2020
Q2Q % growth
145.2M
-22.06%
137.242M7.958M5.80%
Q2 2020
Q2Q % growth
93.2M
-56.73%
95.26M-2.06M-2.16%
Q1 2020
Q2Q % growth
164M
-24.28%
169.893M-5.893M-3.47%
Q4 2019
Q2Q % growth
195.1M
-10.01%
%
Q3 2019
Q2Q % growth
186.3M
-7.91%
%
Q2 2019
Q2Q % growth
215.4M
11.09%
%
Q1 2019
Q2Q % growth
216.6M
18.30%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 4.79% 21.2% 37.1%
Revenue0% 0.64% -0.03% -0.02%